Application Considered for Immunotoxin in Treatment of Graft-vs-Host Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 1991, v. 265, n. 16, p. 2041, doi. 10.1001/jama.1991.03460160015002
- By:
- Publication type:
- Article
Works matching DE "XOMA Corp."
Results: 6
1
2
Deal watch: XOMA and Servier to develop anti-IL-1β antibody for inflammatory diseases.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 3, p. 166, doi. 10.1038/nrd3390
- Publication type:
- Article
3
Firms chase diabetic inflammation with anti-IL-1β antibodies.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 6, p. 533, doi. 10.1038/nbt0610-533
- By:
- Publication type:
- Article
4
Cash crunch quells antibody litigation.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 2, p. 114, doi. 10.1038/nbt0203-114
- By:
- Publication type:
- Article
5
Restored credibility for sepsis therapeutics?
- Published in:
- Nature Biotechnology, 1998, v. 16, n. 13, p. 1303, doi. 10.1038/4263
- By:
- Publication type:
- Article
6
Market machinations.
- Published in:
- Nature, 1990, v. 344, n. 6269, p. 800, doi. 10.1038/344800a0
- By:
- Publication type:
- Article